Sign In
Buy BSEM
$3.96
+0.270 (+7.32%)
At Close: Jul 13, 2026
BioStem Technologies Publicly Files Form 10 Registration Statement with the Securities and Exchange Commission
07:00am, Friday, 10'th Jul 2026
POMPANO BEACH, Fla., July 10, 2026 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC: BSEM) (“BioStem” or the “Company”), a leading regenerative medicine company focused on the development, m
BioStem Technologies Announces Issuance of Four U.S. Design Patents Covering Fenestrated Human Placental Allograft Technologies
08:00am, Wednesday, 08'th Jul 2026
Company Continues to Expand Intellectual Property Portfolio Supporting Advanced Placental Allograft Innovation POMPANO BEACH, FL / ACCESS Newswire / July 8, 2026 / BioStem Technologies, Inc. (OTCID:BS
BioStem Technologies to Present at the Planet MicroCap Las Vegas 2026 Conference
04:05pm, Wednesday, 10'th Jun 2026
POMPANO BEACH, Fla., June 10, 2026 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacturing, and commercialization o
BioStem Technologies Announces Appointment of Three New Members to its Board of Directors
07:00am, Tuesday, 09'th Jun 2026
POMPANO BEACH, Fla., June 09, 2026 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacturing, and commercialization o
BioStem Technologies Announces $2.5 Million Private Placement Financing with its First Institutional Investor
07:00am, Friday, 22'nd May 2026
POMPANO BEACH, Fla., May 22, 2026 (GLOBE NEWSWIRE) -- BioStem Technologies Inc.(OTC: BSEM), a leading regenerative medicine company focused on the development, manufacturing, and commercialization of
BioStem Technologies Q1 Earnings Call Highlights
11:06pm, Friday, 15'th May 2026
BioStem Technologies OTCMKTS: BSEM said its first quarter of 2026 marked a major shift in its business model following a late-January acquisition that moved the company's focus from physician offices
BioStem Technologies, Inc. (BSEM) Q1 2026 Earnings Call Transcript
07:20pm, Thursday, 14'th May 2026
BioStem Technologies, Inc. (BSEM) Q1 2026 Earnings Call Transcript
BioStem Technologies, Inc. (BSEM) Reports Q1 Loss, Tops Revenue Estimates
06:50pm, Thursday, 14'th May 2026
BioStem Technologies, Inc. (BSEM) came out with a quarterly loss of $0.52 per share versus the Zacks Consensus Estimate of a loss of $0.28. This compares to earnings of $0.17 per share a year ago.
BioStem Technologies Reports First Quarter 2026 Financial Results
04:05pm, Thursday, 14'th May 2026
POMPANO BEACH, Fla., May 14, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – BioStem Technologies, Inc. (OTC: BSEM), a leading regenerative medicine company focus
BioStem Technologies to Host First Quarter 2026 Financial Results Conference Call on May 14, 2026
04:05pm, Thursday, 30'th Apr 2026
POMPANO BEACH, Fla., April 30, 2026 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacturing, and commercialization
BioStem Technologies to Showcase Innovation and Clinical Evidence at Symposium on Advanced Wound Care Spring 2026
07:03am, Wednesday, 08'th Apr 2026
POMPANO BEACH, Fla., April 08, 2026 (GLOBE NEWSWIRE) — BioStem Technologies® (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacturing and commercialization of
BioStem Technologies to Showcase Innovation and Clinical Evidence at Symposium on Advanced Wound Care Spring 2026
07:00am, Wednesday, 08'th Apr 2026
POMPANO BEACH, Fla., April 08, 2026 (GLOBE NEWSWIRE) -- BioStem Technologies® (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacturing and commercialization of p
BioStem Technologies to Present at the 25th Annual Needham Virtual Healthcare Conference
04:09pm, Tuesday, 31'st Mar 2026
POMPANO BEACH, Fla., March 31, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focuse
BioStem Technologies Announces the Publication of its Audited Financial Statements for Fiscal Years 2024 and 2025
09:25am, Monday, 30'th Mar 2026
The Company continues its progression towards a Nasdaq uplisting POMPANO BEACH, FL, March 30, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – BioStem Technologies,
BioStem Technologies Q4 Earnings Call Highlights
03:07am, Thursday, 26'th Mar 2026
BioStem Technologies (OTCMKTS:BSEM) used its fourth-quarter and full-year 2025 earnings call to outline a major shift in strategy following the January acquisition of BioTissue's surgical and wound as
